LUO Ping,TU De-hua,HE Xiao-xin,et al.. A evaluation on control influence of the initial drug-resistant towards new pulmonary tuberculosis patients with smear-positive[J]. Chinese Journal of Antituberculosis, 2003, 25(5): 299-301.
1 屠德华.耐药性结核病的流行病学特征和意义[J].中华结核和呼吸杂志,1997,20:327~328.
2 WHO.Anti-tuberculosis drug resistance in the world: prevalence and trends.Report No.2.The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance [M].WHO/CDS/TB,2000:278.
3 张立兴,屠德华,李京生,等.北京市结核菌复发耐药趋势的研究[J].中国防痨杂志,1992,14(1):14.
4 Zhang L X,Tu D H,Enarson D A.The impact of directly-observed treatment on the epidemiology of tuberculosis in beijing [J].Int J Tuberc Lung Dis,2000,4(10):904~910.
5 李群,王晓萌,何海波,等.WHO浙江省结核病耐药监测研究报告[J].中华结核和呼吸杂志,2000,23(12):718~721.
6 王国斌,彭义利,张国龙,等.中国河南WHO结核病耐药监测报告(续)[J].中国防痨杂志,1999,21(4):185~190.
7 汪钟贤.肺结核病的化学治疗与管理[J].中华结核和呼吸杂志,1995,18(4):199~201.
8 Lockman S,Kruuner A.Binkin N,et al.Clinical outcomes of Esto-nian patients with primary multidrug-resistant versus drug-suscepti-ble tuberculosis [J].Clin Infect Dis,2001,32(3):373~380.
9 韩建平,孙淑丽,李仁忠,等.起始耐药与非耐药肺结核患者近、远期疗效观察[J].中华结核和呼吸杂志,2003,26(2):70~72.
10 蔡纪明,陈贤义.中国结核病控制工作典范[M].北京:人民卫生出版社,2003,37~38.